Detalhe da pesquisa
1.
[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study.
Eur J Nucl Med Mol Imaging
; 50(11): 3439-3451, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341747
2.
What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?
World J Urol
; 41(8): 2033-2041, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36484817
3.
Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis.
World J Urol
; 41(3): 641-651, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835886
4.
Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens.
World J Urol
; 40(12): 2931-2937, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342512
5.
Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic).
World J Urol
; 40(2): 419-425, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773475
6.
Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal 18F-fluorocholine PET/CT: 1084 examinations.
Eur J Nucl Med Mol Imaging
; 48(9): 2935-2950, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416958
7.
Prognostic impact of postoperative 123I-metaiodobenzylguanidine scintigraphy: added value of SPECT/CT and semiquantification of the uptake at the surgical site.
Q J Nucl Med Mol Imaging
; 64(1): 131-138, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29409315
8.
18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism.
World J Surg
; 44(11): 3761-3769, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681321
9.
Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France.
BMC Med Imaging
; 20(1): 25, 2020 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32122345
10.
Impact of sodium 18F-fluoride PET/CT, 18F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious for metastasis: a prospective multicentre study.
World J Urol
; 37(8): 1587-1595, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30382380
11.
Diagnostic performance and impact on patient management of 68Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours.
Eur J Nucl Med Mol Imaging
; 45(10): 1710-1720, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29532101
12.
Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
BMC Cancer
; 18(1): 417, 2018 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653564
13.
Editorial Comment: Advances in MRI and PET of the prostate: concurrence or complementarity?
Eur Radiol
; 28(8): 3138-3140, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29858639
14.
Vertebral metastases from neuroendocrine tumours: How to avoid false positives on 68Ga-DOTA-TOC PET using CT pattern analysis?
Eur Radiol
; 28(9): 3943-3952, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29532242
15.
Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer.
Eur J Nucl Med Mol Imaging
; 44(1): 63-70, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27503193
16.
Authors' Reply: 18F-fluorocholine PET/CT in MEN1 Patients with Primary Hyperparathyroidism.
World J Surg
; 45(4): 1256, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386454
17.
Diagnosis of sinusoidal obstruction syndrome by positron emission tomography/computed tomography: report of two cases treated by defibrotide.
Hepatology
; 60(5): 1789-91, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24634000
18.
Phase III Study of 18F-PSMA-1007 Versus 18F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study.
J Nucl Med
; 64(4): 579-585, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36418170
19.
Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. Cancers 2022, 14, 5461.
Cancers (Basel)
; 15(4)2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831697
20.
Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer.
Biomedicines
; 11(9)2023 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760775